Clinical Trials on Gynecological Cancer in Belgium

Total 1709 results

Novosanis NV
Universiteit Antwerpen

Withdrawn

Investigation of Urinary Biomarkers for the Detection of Prostate Cancer (URODETECT-WP2)

Prostate Cancer | Urine | Liquid Biopsy

Belgium
Jules Bordet Institute

Active, not recruiting

Assessment of (Chemo)RT-related Dysphagia in HNC Patients Based on Cough-related Acoustic Features

Head and Neck Cancer | Dysphagia

Belgium
University Ghent
KU Leuven; Vrije Universiteit Brussel; Universiteit Antwerpen; Kom Op Tegen Kanker and other collaborators

Recruiting

Efficacy of Offering a Self-sampling Device by the GP to Reach Underscreened Women (ESSAG)

Cervical Cancer

Belgium
University Hospital, Antwerp
Amgen

Unknown

lead-in FOLICOLOR Trial: Following Therapy Response Through Liquid Biopsy in Metastatic Colorectal Cancer Patients

Metastatic Colorectal Cancer

Belgium
Jules Bordet Institute
Roche Pharma AG

Terminated

COVID-19: Immune Response in Patients With Cancer Undergoing mRNA Vaccination Against SARS-CoV-2 (I-SPARC)

Cancer

Belgium
European Organisation for Research and Treatment...

Withdrawn

TAK-700 in Castration Resistant Prostate Cancer

Prostate Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven
Flemish League Against Cancer

Terminated

Pathological Validation of Functional Imaging in Head and Neck Squamous Cell Carcinoma

Head and Neck Cancer

Belgium
Jules Bordet Institute

Completed

The Jules Bordet Institute Molecular Profiling Program Feasibility Trial (PRECISION-F)

Metastatic Melanoma | Colorectal Cancer Metastatic | Metastatic Non-Small Cell Lung Carcinoma

Belgium
University Hospital, Ghent

Completed

Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial

Bowen's Disease | Superficial Basal Cell Carcinoma

Belgium
Universitaire Ziekenhuizen KU Leuven
Ipsen

Recruiting

Long-term Better Than Short-term ADT With Salvage RT (LOBSTER)

Prostate Cancer

Belgium
Eli Lilly and Company

Completed

Study of IMC-11F8 in Participants With Colorectal Cancer

Metastatic Colorectal Cancer

Spain, Belgium
Jules Bordet Institute

Recruiting

Assessment of Swallowing Function and Quality of Life in Oropharyngeal Cancer Patients Treated by Chemo-radiotherapy (SwallPEG)

Oropharyngeal Cancer

Belgium
GZA Ziekenhuizen Campus Sint-Augustinus

Completed

Evaluation of Persistent Postsurgical Pain After Breast Surgery With a Pectoral Nerves Block (Pecs) Type II

Breast Cancer | Chronic Post-Procedural Pain

Belgium
Jules Bordet Institute

Completed

Near-Infrared Imaging of Peritoneal Carcinomatosis From Colorectal Cancer (OC-AP-ICG-IV)

Colorectal Cancer | Peritoneal Carcinomatosis

Belgium
University Hospital, Gasthuisberg

Withdrawn

Design of the EFECTS Trial (EFECTS)

Esophageal Cancer

Belgium
Celyad Oncology SA
Merck Sharp & Dohme LLC

Recruiting

Study of Pembrolizumab Treatment After CYAD-101 With FOLFOX Preconditioning in Metastatic Colorectal Cancer

Unresectable Metastatic Colorectal Cancer

Belgium, United States
Lytix Biopharma AS
ICON plc; Theradex

Completed

LTX-315 in Patients With Transdermally Accessible Tumours as Monotherapy or Combination With Ipilimumab or Pembrolizumab

Melanoma | Lymphoma | Cancer | Breast Cancer | Head and Neck Cancer | Triple-Negative Breast Cancer

United Kingdom, France, Norway, Belgium, Italy
Universitaire Ziekenhuizen KU Leuven
Universiteit Antwerpen

Recruiting

Why do Patients Report Lymphedema After Breast Cancer Treatment Without an Objective Measurable Swelling (LymphSens)

Breast Cancer | Lymphedema | Sensory Processing Disorder

Belgium
Jules Bordet Institute
Breast International Group

Completed

BIG Molecular Screening Feasibility Study (BIG MS Pilot)

Metastatic Breast Cancer

Belgium, Spain, Germany, United Kingdom
Celyad Oncology SA

Unknown

Dose Escalation and Dose Expansion Phase I Study to Assess the Safety and Clinical Activity of Multiple Doses of NKR-2 Administered Concurrently With FOLFOX in Colorectal Cancer With Potentially Resectable Liver Metastases (SHRINK)

Colon Cancer Liver Metastasis

Belgium
European Organisation for Research and Treatment...

Unknown

LungTech: Stereotactic Body Radiotherapy (SBRT) of Inoperable Centrally Located NSCLC (LungTech)

Non-small Cell Lung Cancer Stage I | Non-small Cell Lung Cancer Stage II

Germany, Belgium, United Kingdom, Switzerland
Universiteit Antwerpen
University Hospital, Antwerp

Active, not recruiting

First-void Urine Samples for the Follow-up of Women Treated for High-grade Cervical Intraepithelial Neoplasia (CIN)

Cervical Cancer

Belgium
Eli Lilly and Company

Completed

Multicenter Phase 2 Trial Evaluating Cisplatin-Gemcitabine With Concomitant Thoracic Radiotherapy for Treatment of Inoperable Stage III Non Small Cell Lung Cancer

Non Small Cell Lung Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Lymphoedema and Nocturia/ Nocturnal Polyuria After Pelvic Lymph Node Dissection for Urogenital Cancer (UroLymph)

Urogenital Cancer | Lower Limb Lymphedema

Belgium
Jessa Hospital

Withdrawn

A Novel Skin Barrier Protectant for Acute Radiodermatitis (CASP-ORL)

Skin Diseases | Head and Neck Cancer | Radiation Toxicity | Radiodermatitis | Radiation Dermatitis

Belgium
University Hospital, Ghent

Recruiting

Prediction of Surgical Resectability After FOLFIRINOX Chemotherapy for Borderline Resectable and Locally Advanced Pancreatic Cancer: the Role of Diffusion Weighted Magnetic Resonance Imaging, Radiomics and Liquid Biopsy (PeRFormanCe Trial) (PeRFormanCe)

Pancreatic Cancer

Belgium
European Organisation for Research and Treatment...

Completed

R101933 Combined With Chemotherapy in Treating Patients With Metastatic Breast Cancer That Has Not Responded to Previous Chemotherapy

Breast Cancer

France, Belgium
Universitair Ziekenhuis Brussel

Recruiting

Total Neoadjuvant Treatment of Rectal Cancer by MRI-guided Radiotherapy (TNTRect)

Rectal Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Completed

Neoadjuvant Bevacizumab, Capecitabine and Radiation Therapy With or Without Oxaliplatin Locally Advanced Rectal Cancer (AXEBEAM)

Locally Advanced Rectal Cancer

Belgium
European Organisation for Research and Treatment...

Completed

Pazopanib Hydrochloride, Paclitaxel, and Carboplatin in Treating Patients With Refractory or Resistant Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Ovarian Cancer | Fallopian Tube Cancer | Primary Peritoneal Cavity Cancer

Belgium, Netherlands, Spain
Cliniques universitaires Saint-Luc- Université...

Unknown

Prehabilitation in Frail Colon Cancer

Colon Cancer | Fragility

Belgium
DeuterOncology

Recruiting

Study to Determine the Safety and Pharmacokinetics of DO-2 in Patients With Advanced or Refractory Solid Tumours

Adult Solid Tumor | Lung Cancer | Advanced Solid Tumor | Non-small Cell Lung Cancer | Non-small Cell Carcinoma | Refractory Tumor | Hereditary Renal Papillary Cancer

France, Belgium, Netherlands
Universitaire Ziekenhuizen KU Leuven

Recruiting

Lymphoedema and Nocturia/Nocturnal Polyuria After Pelvic LND for Urogenital Cancer (UroLymph)

Nocturia | Urogenital Cancer | Lower Limb Lymphedema | Nocturnal Polyuria

Belgium
KU Leuven

Unknown

Serum, Plasma, DNA and Tissue Bank in Chronic Obstructive Pulmonary Disease and Lung Cancer

Chronic Obstructive Pulmonary Disease | Lung Cancer

Belgium
Universitaire Ziekenhuizen KU Leuven

Recruiting

Observational Study on Extreme Hypofractionation for Localized Prostate Cancer (OBELIX PCa)

Prostate Cancer | Radiotherapy | SBRT

Belgium
Jules Bordet Institute

Active, not recruiting

Neoadjuvant Regorafenib in Combination With Nivolumab and Short-course Radiotherapy in Stage II-III Rectal Cancer (REGINA)

Rectal Cancer Stage II | Rectal Cancer Stage III

Belgium, France
Universitaire Ziekenhuizen KU Leuven

Completed

Early Metabolic Response in Locally Advanced Esophageal Cancer Undergoing Induction Chemoradiotherapy

Esophageal Carcinoma (Squamous Cell Carcinoma - Adenocarcinoma)

Belgium
University Hospital, Ghent
AZ Sint-Jan AV; AZ Delta; Kom Op Tegen Kanker; AZ Sint-Lucas Gent

Recruiting

Evaluation of a Decision Aid Tool in Rectal Cancer patiënts

Low Anterior Resection Syndrome | Rectal Cancer

Belgium
Boehringer Ingelheim

Completed

A Study to Find the Best Dose of BI 905711 in Combination With Chemotherapy and to Test Whether This Dose Helps People With Advanced Gastrointestinal Cancers

Gastrointestinal Cancer, Metastatic

Belgium, United States, France, Japan, China
Sanofi
Regeneron Pharmaceuticals

Completed

A Study to Evaluate the Effects of Aflibercept on QTc Interval in Cancer Patients (QUTIE)

Cancer

United States, Romania, Germany, Italy, Turkey, Belgium, Denmark
European Organisation for Research and Treatment...

Completed

Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Breast Cancer

Belgium, Netherlands, France
Universitair Ziekenhuis Brussel
Brugmann University Hospital

Recruiting

Longitudinal Neurocognitive, Psychosocial and Health-related Quality of Life Assessment in Advanced Cancer Survivors Treated With Immunotherapy and the Efficacy of Integrative Neurocognitive Remediation Therapy (CognIT)

Quality of Life | Cognitive Dysfunction | Psychological Distress | Immunotherapy | Cognitive Behavioral Therapy | Cancer Survivors | Cognitive Remediation | Neuropsychology | Psycho-Oncology

Belgium
University Hospital, Ghent

Completed

Feasibility of Radiotherapy and Concomitant Gemcitabine and Oxaliplatin in Locally Advanced Pancreatic Cancer and Distal Cholangiocarcinoma

Locally Advanced and Unresectable, But Non-metastatic Pancreatic Adenocarcinoma or Cholangiocarcinoma

Belgium
Universitaire Ziekenhuizen KU Leuven
Pfizer

Completed

SU11248 as Consolidation After Response to Taxanes in Metastatic Breast Cancer

Metastatic Breast Cancer

Belgium
AstraZeneca

Completed

Faslodex Registry: Fulvestrant in Current Clinical Practice

Metastatic Breast Cancer

Belgium
University Hospital, Ghent

Completed

Intraoperative Intraperitoneal Chemoperfusion to Treat Peritoneal Minimal Residual Disease in Stage III Ovarian Cancer (OvIP1)

Ovarian Cancer | Primary Peritoneal Cancer

Belgium
Novartis Pharmaceuticals

Completed

Safety of Everolimus and Pemetrexed in Lung Cancer Patients

Non Small Cell Lung Cancer

Belgium, Australia, Germany
Universiteit Antwerpen
End-of-Life Research Group

Completed

Distress and Quality of Life During the Diagnostic Phase of a Suspected Serious Lung Disease (DIADISS)

Suspected Lung Cancer

Belgium
University Hospital, Ghent
Hasselt University; Jessa Hospital; AZ Sint-Jan AV; AZ Delta; Ziekenhuis Oost-Limburg

Recruiting

Physical Activity Coaching After Surgery for Patients With Resectable Non-small Cell Lung Cancer (LucaMove)

Non Small Cell Lung Cancer | Non-small Cell Carcinoma

Belgium
Eli Lilly and Company

Terminated

A Study to Treat Small Cell Lung Cancer With a Combination of Cisplatin, Pemetrexed, and Radiotherapy

Small Cell Lung Cancer | SCLC | Carcinoma, Small Cell

Netherlands, Belgium

Clinical Trials on Gynecological Cancer in Belgium

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Kingdom

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations